4Filing Date: Sep 14, 2026
Moderna (MRNA)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001682852-26-000174
Total Value$5.30M
Trades4
Insiders1
Transaction Details
Mock James M
Chief Financial Officer·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-19.84K
Price$0.00
Total Value$0
Shares Owned After43.64K
Transaction DateSep 10, 2026
Exercise Price$30.96
ExpiresMar 1, 2035
10b5-1
Footnotes ▸
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026. | 25% of this option vested and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Mock James M
Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-15.00K
Price$134.49
Total Value$2.02M
Shares Owned After59.38K
Transaction DateSep 10, 2026
10b5-1
Footnotes ▸
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
Mock James M
Chief Financial Officer·Direct
Exercise · Acquire
Common Stock
Shares+19.84K
Price$30.96
Total Value$614.1K
Shares Owned After94.21K
Transaction DateSep 10, 2026
10b5-1
Footnotes ▸
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
Mock James M
Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-19.84K
Price$134.49
Total Value$2.67M
Shares Owned After74.38K
Transaction DateSep 10, 2026
10b5-1
Footnotes ▸
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
Post-Transaction Holdings
Mock James M · Chief Financial Officer
| Security | Shares | Change |
|---|---|---|
| Common Stock | 59.38K | -15.00K (-20.17%) |
| Stock Option (Right to Buy) | 43.64K | -19.84K (-31.25%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-10
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Moderna, Inc. (MRNA)
CIK: 0001682852
--- Reporting Owner ---
Name: Mock James M
CIK: 0001736359
Role: Officer (Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-10 | Code: M (Exercise of derivative)
Shares: +19,836 | Price: $30.96
Total Value: $614,122.56
Shares Owned After: 94,211 | Ownership: D (Direct)
Footnotes:
[F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
[Transaction #2]
Security: Common Stock
Date: 2026-09-10 | Code: S (Open market sale)
Shares: -19,836 | Price: $134.49
Total Value: $2,667,743.64
Shares Owned After: 74,375 | Ownership: D (Direct)
Footnotes:
[F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
[Transaction #3]
Security: Common Stock
Date: 2026-09-10 | Code: S (Open market sale)
Shares: -15,000 | Price: $134.49
Total Value: $2,017,350.00
Shares Owned After: 59,375 | Ownership: D (Direct)
Footnotes:
[F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
--- Derivative Transactions ---
[Transaction #1]
Security: Stock Option (Right to Buy)
Date: 2026-09-10 | Code: M (Exercise of derivative)
Shares: -19,836 | Price: $0.00
Exercise Price: $30.96
Exercisable: N/A | Expires: 2035-03-01
Shares Owned After: 43,642 | Ownership: D (Direct)
Footnotes:
[F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
[F2] 25% of this option vested and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
--- Footnotes (Complete Index) ---
F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2026.
F2: 25% of this option vested and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
--- Signature ---
/s/ /s/ James Dillon, As Attorney-in-Fact (2026-09-14)